Filed under: Computers
Today, most people suffering from hearing loss can choose to either buy a hearing aid, or, in extreme cases, have a cochlear implant placed in their problematic ear. Both options, however, have their drawbacks. Hearing aids can be cumbersome, implants can completely destroy any hearing left in an ear, and neither method ever replicates the same quality of perception that the natural ear allows. Scientists have been trying to come up with less invasive, drug-based methods to treat hearing loss, but have so far been unable to find a way to introduce pharmaceutical treatment to the deep inner ear, where most problems originate. Researchers at Draper Laboratory in Cambridge, Massachusetts, however, have recently developed a device that could finally penetrate the darker depths of the human ear, and deliver medication in a timely and measured way.
The gadget, which is no bigger than a AA battery, consists of a pump and drug reservoir, and is implanted directly into the temporal bone of the ear. An attached tube, meanwhile, delivers the treatment directly into the cochlea. The team at Draper has already tested the device on guinea pigs, and, according to Technology Review, administered the drugs without causing any damage to the animals’ ears. In order to use the device on humans, though, they’ll have to make it still smaller, but the scientists are hopeful that they can have their brainchild ready for clinical testing within five years.
Continue reading Draper Lab Device Dispenses Drugs to Fight Hearing Loss
Draper Lab Device Dispenses Drugs to Fight Hearing Loss originally appeared on Switched on Mon, 05 Jul 2010 08:00:00 EST. Please see our terms for use of feeds.
Read | Permalink | Email this | Comments
Recent developments in medical science have enabled patients with heart conditions to experience unprecedented methods of surgery and rehabilitation. Tireless and precise 
Often, when people talk about the future of user interaction with computers, the go-to reference is Steven Spielberg’s ‘
Ever since the age of four, Ben Michaels has suffered from amblyopia, or severe lazy eye syndrome, in his right eye. The condition gradually weakened the eye’s vision, and when Ben was at the tender age of six, was at risk of permanent blindness. Desperate, Ben’s mother Maxine sought the advice of Ken Nischal, a consultant at Great Ormond Street Children’s Hospital. Nischal’s professional recommendation? A steady diet of 
Researchers at Harvard and the Children’s Hospital in Boston recently combined lung and blood vessel cells with microchip technology to create what they’ve dubbed a “lung-on-a-chip.” It may sound like the name of a cannibalistic afternoon snack, but the new gadget reportedly behaves and reacts like real lung tissue, and could radically change the way in which medical researchers study human lungs. 